THYROCARENSEThyrocare Technologies LimitedLowNeutral
Announced Thu, 7 May · 17:34 IST

Thyrocare Technologies Limited has informed the Exchange about cancellation of earning conference call

Board & Shareholder Meetings View source PDF

THYROCARE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.3%1-day move
₹472.50
prior close
₹493.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+4.2+5.4+5.2+3.0+1.3-0.1+1.2-0.5-2.4-0.7+10.1+14.2+10.9
Up moveDown movePending
AI summary

Thyrocare Technologies has cancelled its scheduled earnings conference call originally planned for May 7, 2026 at 5:30 PM IST. The call was meant to discuss the company's audited financial results for Q4 and full year ended March 31, 2026. The company cited 'unforeseen circumstances' as the reason for cancellation. This is the third intimation related to this call, following previous notices on April 29 and May 4, 2026. A revised schedule for the earnings call will be announced separately.

Likely market impact

The cancellation delays investor communication about the company's FY2026 financial performance. While the vague 'unforeseen circumstances' raises mild concern, no specific reasons were disclosed. Shareholders should monitor for the revised call announcement to get clarity on the company's results.